Bogna Cichowska-Duma, general director of the Employers' Association of Innovative Pharmaceutical Companies (INFARMA), the voice of 28 leading innovative companies in Poland, discusses the challenges and opportunities for doing research and business in Poland. Furthermore, she points out the importance of seeing healthcare expenses as investments not solely costs and the country’s amazing potential, especially in the area of clinical trials.
As general director, could you introduce to our international readers the Employers' Association of Innovative Pharmaceutical Companies (INFARMA)?
"Poland remains the largest clinical trials market in CEE – however - both patient participation and site penetration rates indicate a potential for growth."
